https://www.selleckchem.com/pr....oducts/gsk269962.htm
Independent predictors of local control and survival were identified that can contribute to better treatment personalization. Independent predictors of local control and survival were identified that can contribute to better treatment personalization. It is unclear whether the de-escalated therapy that omits anthracycline-based chemotherapy is as beneficial as standard therapy for patients with stage I human epidermal growth factor receptor 2-positive (HER2 ) early breast cancer. We retrospectively investigated 95 patients with pathol
Curtir
Comentario
Compartilhar
